CoChat

Developability studies before initiation of process development: Improving manufacturability of monoclonal antibodies

Open access
Yang, Xiaoyu, Xu, Wei, Dukleska, Svetlana, Benchaar, Sabrina, Mengisen, Selina, Antochshuk, Valentyn, Cheung, Jason, Mann, Leslie, Babadjanova, Zulfia, Rowand, Jason, Gunawan, Rico, McCampbell, Alexander, Beaumont, Maribel, Meininger, David, Richardson, Daisy, Ambrogelly, Alexandre · 2013 · mAbs
Cited by 115

The DOI matches its Crossref record.

Abstract

Monoclonal antibodies constitute a robust class of therapeutic proteins. Their stability, resistance to stress conditions and high solubility have allowed the successful development and commercialization of over 40 antibody-based drugs. Although mAbs enjoy a relatively high probability of success compared with other therapeutic proteins, examples of projects that are suspended due to the instability of the molecule are not uncommon. Developability assessment studies have therefore been devised to identify early during process development problems associated with stability, solubility that is insufficient to meet expected dosing or sensitivity to stress. This set of experiments includes short-term stability studies at 2-8 þC, 25 þC and 40 þC, freeze-thaw studies, limited forced degradation studies and determination of the viscosity of high concentration samples. We present here three case studies reflecting three typical outcomes: (1) no major or unexpected degradation is found and the study results are used to inform early identification of degradation pathways and potential critical quality attributes within the Quality by Design framework defined by US Food and Drug Administration guidance documents; (2) identification of specific degradation pathway(s) that do not affect potency of the molecule, with subsequent definition of proper process control and formulation strategies; and (3) identification of degradation that affects potency, resulting in program termination and reallocation of resources.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/mabs.25269

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 115

Metadata

Authors
Yang, X., Xu, W., Dukleska, S., Benchaar, S., Mengisen, S., Antochshuk, V., Cheung, J., Mann, L., Babadjanova, Z., Rowand, J., Gunawan, R., McCampbell, A., Beaumont, M., Meininger, D., Richardson, D., & Ambrogelly, A.
Venue
mAbs
Published
2013-09
Volume
5
Issue
5
Pages
787-794
ISSN
  • 1942-0862 (ISSN-L)
  • 1942-0870
OpenAlex
W2062442246
Cited by
115
References
0
FWCI
3.36
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Developability studies before initiation of process development: Improving manufacturability of monoclonal antibodies. https://app.cochat.ai/papers/10.4161/mabs.25269
The paper
Yang, X., Xu, W., Dukleska, S., Benchaar, S., Mengisen, S., Antochshuk, V., Cheung, J., Mann, L., Babadjanova, Z., Rowand, J., Gunawan, R., McCampbell, A., Beaumont, M., Meininger, D., Richardson, D., & Ambrogelly, A. (2013). Developability studies before initiation of process development: Improving manufacturability of monoclonal antibodies. mAbs. https://doi.org/10.4161/mabs.25269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.